Prefronto–cerebellar transcranial direct current stimulation improves visuospatial memory, executive functions, and neurological soft signs in patients with euthymic bipolar disorder

Neuropsychiatric Disease and Treatment

Volumn 11, Issue , 2015, Pages 2265-2270

  Minichino, Amedeo ^a   Bersani, Francesco Saverio ^a   Bernabei, Llaura ^a   Spagnoli, Francesco ^a   Vergnani, Lucilla ^a   Corrado, Alessandra ^a   Taddei, Ines ^a   Biondi, Massimo ^a   Chiaie, Rroberto Delle ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Cerebellum; Cognition; Dorsolateral prefrontal cortex; Neuropsychology

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; LITHIUM SALT; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CEREBELLUM CORTEX; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE DURATION; EXECUTIVE FUNCTION; FEMALE; HUMAN; MALE; MEMORY; MENTAL PERFORMANCE; MENTAL TASK; MOTOR COORDINATION; NEUROLOGIC EXAMINATION; NEUROLOGICAL SOFT SIGN; NEUROMODULATION; ONSET AGE; OUTPATIENT; PREFRONTAL CORTEX; SENSORIMOTOR INTEGRATION; TRANSCRANIAL DIRECT CURRENT STIMULATION; VISUOSPATIAL MEMORY;

EID: 84940688707     PISSN: None     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S79108     Document Type: Article

References (40)

1. Trede K, Salvatore P, Baethge C, Gerhard A, Maggini C, Baldessarini RJ. Manic-depressive illness: evolution in Kraepelin’s Textbook, 1883–1926. Harv Rev Psychiatry. 2005;13(3):155–178
2. Rovai L, Maremmani AG, Rugani F, et al. Do Akiskal and Mallya’s affective temperaments belong to the domain of pathology or to that of normality? Eur Rev Med Pharmacol Sci. 2013;17(15):2065–2079
3. Kessler RC, Akiskal HS, Ames M, et al. Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers. Am J Psychiatry. 2006;163(9):1561–1568
4. Kogan JN, Otto MW, Bauer MS, et al. Demographic and diagnostic characteristics of the first 1,000 patients enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Bipolar Disord. 2004;6(6):460–469
5. Tohen M, Zarate CA Jr, Hennen J, et al. The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence. Am J Psychiatry. 2003;160(12):2099–2107
6. Bersani G, Polli E, Valeriani G, et al. Facial expression in patients with bipolar disorder and schizophrenia in response to emotional stimuli: a partially shared cognitive and social deficit of the two disorders. Neuropsychiatr Dis Treat. 2013;9:1137–1144
7. Campanella S. Why it is time to develop the use of cognitive event-related potentials in the treatment of psychiatric diseases. Neuropsychiatr Dis Treat. 2013;9:1835–1845
8. Deckersbach T, Nierenberg AA, Kessler R, et al. RESEARCH: Cognitive rehabilitation for bipolar disorder: An open trial for employed patients with residual depressive symptoms. CNS Neurosci Ther. 2010;16(5): 298–307
9. Martínez-Arán A, Vieta E, Colom F, et al. Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome. Bipolar Disord. 2004;6(3):224–232
10. Robinson LJ, Thompson JM, Gallagher P, et al. A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. J Affect Disord. 2006;93(1–3):105–115
11. Dazzan P, Murray RM. Neurological soft signs in first-episode psychosis: a systematic review. Br J Psychiatry Suppl. 2002;43: s50–s57
12. Bersani G, Clemente R, Gherardelli S, Bersani FS, Manuali G. Obstetric complications and neurological soft signs in male patients with schizophrenia. Acta Neuropsychiatr. 2012;24(6):344–348
13. Nasrallah HA, Tippin J, McCalley-Whitters M. Neurological soft signs in manic patients. A comparison with Schizophrenic and control groups. J Affect Disord. 1983;5(1):45–50
14. Goswami U, Basu S, Khastgir U, et al. Neurobiological characterization of bipolar affective disorders: a focus on tardive dyskinesia and soft neurological signs in relation to serum dopamine Beta hydroxylase activity. Indian J Psychiatry. 1998;40(3):201–211
15. Goswami U, Sharma A, Khastigir U, Ferrier IN, Young AH, Gallagher P, et al. Neuropsychological dysfunction, soft neurological signs and social disability in euthymic patients with bipolar disorder. Br J Psychiatry. 2006;188:366–373
16. Dimitri-Valente G, Rigucci S, Manfredi G, Girardi P, Ferracuti S. Neurological soft signs: meaning and relevance along the course of psychiatric illness. An objective and rapid screening for psychosis?. Riv Psichiatr. 2012;47(6):465–478. Italian
17. Benson BE, Willis MW, Ketter TA, et al. Interregional cerebral metabolic associativity during a continuous performance task (Part II): differential alterations in bipolar and unipolar disorders. Psychiatry Res. 2008;164(1):30–47
18. Kimbrell TA, Ketter TA, George MS, et al. Regional cerebral glucose utilization in patients with a range of severities of unipolar depression. Biol Psychiatry. 2002;51(3):237–252
19. Minichino A, Bersani FS, Spagnoli F, et al. Prefronto-cerebellar transcranial direct current stimulation improves sleep quality in euthymic bipolar patients: a brief report. Behav Neurol. 2014;2014:876521
20. Minichino A, Bersani FS, Trabucchi G, et al. The role of cerebellum in unipolar and bipolar depression: a review of the main neurobiological findings. Riv Psichiatr. 2014;49(3):124–131
21. Delle Chiaie R et al., Bipolar spectrum disorders in patients with cerebellar lesions. a comparison with Parkinson’s disease. Journal of Nervous and Mental Disease 2015. In press
22. Andreasen NC, Nopoulos P, O’Leary DS, Miller DD, Wassink T, Flaum M. Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms. Biol Psychiatry. 1999;46(7):908–920
23. Bersani FS, Biondi M. Historical recurrences in psychiatry: somatic therapies. Riv Psichiatr. 2012;47(1):1–4. Italian
24. Medeiros LF, de Souza IC, Vidor LP, et al. Neurobiological effects of transcranial direct current stimulation: a review. Front Psychiatry. 2012;3:110
25. Poreisz C, Boros K, Antal A, Paulus W. Safety aspects of transcranial direct current stimulation concerning healthy subjects and patients. Brain Res Bull. 2007;72(4–6):208–214
26. Mondino M, Bennabi D, Poulet E, Galvao F, Brunelin J, Haffen E. Can transcranial direct current stimulation (tDCS) alleviate symptoms and improve cognition in psychiatric disorders? World J Biol Psychiatry. 2014;15(4):261–275
27. Pope PA, Miall RC. Task-specific facilitation of cognition by cathodal transcranial direct current stimulation of the cerebellum. Brain Stimul. 2012;5(2):84–94
28. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62
29. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133: 429–435
30. Bersani FS, Minichino A, Fattapposta F, Mannarelli D, Pauletti C, Imperatori C, et al. P300 component in euthymic patients with bipolar disorder type I, bipolar disorder type II and healthy controls: a preliminary event-related potential study. Neuroreport. 2015;26(4): 206–210
31. Boggio PS, Ferrucci R, Rigonatti SP, et al. Effects of transcranial direct current stimulation on working memory in patients with Parkinson’s disease. J Neurol Sci. 2006;249(1):31–38
32. Shin MS, Park SY, Park SR, Seol SH, Kwon JS. Clinical and empirical applications of the Rey-Osterrieth Complex Figure Test. Nat Protoc. 2006;1(2):892–899
33. Buchanan RW, Heinrichs DW. The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Res. 1989;27(3):335–350
34. Castellanos FX, Sonuga-Barke EJ, Milham MP, Tannock R. Characterizing cognition in ADHD: beyond executive dysfunction. Trends Cogn Sci. 2006;10(3):117–123
35. Heinrichs RW, Zakzanis KK. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology. 1998;12(3): 426–445
36. Loeber S, Vollstädt-Klein S, von der Goltz C, Flor H, Mann K, Kiefer F. Attentional bias in alcohol-dependent patients: the role of chronicity and executive functioning. Addict Biol. 2009;14(2):194–203
37. Mossner R, Mikova O, Koutsilieri E, et al. Consensus paper of the WFSBP Task Force on Biological Markers: biological markers in depression. World J Biol Psychiatry. 2007;8(3):141–174
38. Bersani FS, Minichino A, Fojanesi M, Gallo M, Maglio G, Valeriani G, et al. Cingulate Cortex in Schizophrenia: its relation with negative symptoms and psychotic onset. A review study. Eur Rev Med Pharmacol Sci. 2014;18(22):3354–3367
39. Larøi F, Raballo A. Notes from Underground: Are Cognitive-Enhancing Drugs Respecting their Promises? Front Psychol. 2010;1:158
40. Mittal VA, Dean DJ, Bernard JA, et al. Neurological soft signs predict abnormal cerebellar-thalamic tract development and negative symptoms in adolescents at high risk for psychosis: a longitudinal perspective. Schizophr Bull. 2014;40(6):1204–121